Articles related to PSYCHEDELICS

Discover the advancements in MDD pharmacotherapy that promise to expand treatment options and address unmet needs.

The newly released guidelines for psychedelic-assisted therapy by APPA and BrainFutures provide a comprehensive framework for mental health professionals. Explore the guidelines to understand the benchmarks for safety, ethics, and best practices in this emerging field.

Recent phase 3 clinical trials have demonstrated the eye-opening potential of MDMA in the treatment of PTSD when paired with psychotherapy, providing a new method of patient care.

The preliminary findings suggest a potential new direction for managing chronic pain in PTSD, inviting further research and consideration in the clinical field.

AMA’s introduction of a CPT III code for psychedelic therapies denotes a potential paradigm shift in the treatment of mental health conditions, inviting clinicians to explore these emerging modalities.

Discover how the FDA’s first draft guidance on psychedelic drugs outlines a path for future medical treatments, addressing crucial considerations from study design to safety measures. Learn more about how this pivotal step could transform the therapeutic landscape.